Abstract
The relationship between H. pylori and functional dyspepsia is controversial. Hypothesizing that subjects with a more intense immune response to H. pylori (and hence higher antibody titers) would be at greater risk of dyspepsia, we aimed to identify risk factors for the development of dyspeptic symptoms. In all, 491 healthy blood donors with no history of peptic ulceration and 74 consecutive patients with a confirmed diagnosis of functional dyspepsia were studied. Symptoms and potential risk factors [nonsteroidal antiinflammatory drugs (NSAIDs), alcohol, and smoking] were measured by a validated questionnaire. H. pylori status was determined by IgG antibodies using a validated ELISA test with a cutoff titer for a positive serology of 10 units/ml. Logistic regression analysis assessed the association between risk factors and dyspepsia. Among blood donors, 21% (95% CI 17.6–24.8) reported dyspepsia (pain localized to the upper abdomen); 7.7% (95% CI 5.5–10.4) had frequent dyspepsia (>6 times in the prior year). The age-adjusted prevalence of H. pylori was not significantly different in blood donors with (39.5%, 95% CI 24.0–56.6) and without frequent dyspepsia (34.2%, 95% CI 29.8–38.36), but was significantly greater in patients with functional dyspepsia (68.8%, 95% CI 57.3–77.9). In the combined study population of blood donors and patients with functional dyspepsia, logistic regression adjusting for age identified the following independent risk factors for frequent dyspepsia: high serum antibody levels against H. pylori (OR for IgG titer >50 units/ml vs H. pylori titers 11–50 units/ml 4.6, 95% CI 2.7–7.8) and consumption of standard NSAIDs (OR 2.4, 95% CI 1.3–4.5). In contrast, alcohol (OR 0.6, 95% CI 0.3–1.0), smoking (OR 1.5, 95% CI 1.0–2.3) or positive H. pylori serology with titers ≤50 units/ml (OR 1.6, 95% CI 0.8–2.9) were not associated with frequent dyspepsia. In conclusion, in a subgroup of H. pylori-infected subjects who have high antibody titers, H. pylori appears to be associated with functional dyspepsia.
Similar content being viewed by others
References
Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, Gugler R, Malagelada J, Nyrén O, Petersen H, Piper D: Management of dyspepsia: Report of a working party. Lancet 1:576–579, 1988
Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN: Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40, 1988
Lambert JR, Dunn K, Borromeo M, Korman MG, Hansky J: Campylobacter pylori–a role in non-ulcer dyspepsia? Scand J Gastroenterol Suppl 160:7–13, 1989
Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE: Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 82:1149–1152, 1987
Greenberg RE, Bank S: The prevalence of Helicobacter pylori in nonulcer dyspepsia. Arch Intern Med 150:2053–2055, 1990
O'Morain C, Gilvarry J: Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Scand J Gastroenterol Suppl 28:30–33, 1993
Vaira D, Holton J, Ainley C, Falzon M, Osborn J, D'Anna L, Romanos A, Chandrakumaran K, McNeil I: Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Ital J Gastroenterol 24:400–404, 1992
Talley NJ: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 106:1174–1183, 1994
Marshall BJ: Virulence and pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol 6:121–124, 1991
Wyatt JI, Rathbone BJ, Heatley RV: Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 39:863–870, 1986
Rathbone BJ, Wyatt JI, Worsley BW, Shires SE, Trejdosiewicz LK, Heatley RV, Losowsky MS: Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27:642–647, 1986
Talley NJ, McNeil D, Piper DW: Environmental factors and chronic unexplained dyspepsia. Association with acetaminophen but not other analgesics, alcohol, coffee, tea, or smoking. Dig Dis Sci 33:641–648, 1988
Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ: Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 40:1345–1350, 1995
Holtmann G, Goebell H, Holtmann M, Talley NJ: Dyspepsia in healthy blood donors: Pattern of symptoms and association with Helicobacter pylori Dig Dis Sci 39:1090–1098, 1994
Blaser MJ, Duncan DJ: Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme linked immunoabsorbent assay. Infect Immun 33:292–298, 1984
Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ: Serodiagnosis of Helicobacter pylori: Comparison of enzyme-linked immunosorbent assay. J Clin Microbiol 29:1635–1639, 1991
Talley NJ, Phillips SF, Melton LJI, Wiltgen C, Zinsmeister AR: A patient questionnaire to identify bowel disease. Ann Intern Med 111:671–674, 1989
Holtmann G, Goebell H, Talley NJ: Dyspepsia in consulters and nonconsulters: Prevalence, health-care seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 6:917–924, 1994
Locke GR, Talley NJ, Weaver AL, Zinsmeister AR: The fluctuating course of functional bowel disease: A four-year community study. Gastroenterology 106:A16, 1994
Talley NJ, Zinsmeister AR, Schleck CD, Melton LJI, Melton LJ: Smoking, alcohol and analgesics in dyspepsia and among dyspepsia subgroups: Lack of an association in the community. Gut 35:619–624, 1994
Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR: Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105:1378–1386, 1993
Talley NJ, Zinsmeister AR, Schleck CD, Melton LJI: Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 102:1259–1268, 1992
Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 4:145–160, 1991
Thompson WG, Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology 79:283–288, 1980
Gardner M, Altman DG: Calculating confidence intervals for proportions and their differences. In Statistics with Confidence–Confidence Intervals and Statistical Guidelines. M Gardner, DG Altman (eds). BMJ-Group, London, 1991, pp 28–33
SAS Institute Inc: SAS/STAT User's Guide, Release 6.03. Cary, North Carolina, SAS Institute Inc., 1988
Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up. The optimal regimen cures Helicobacter-Induced Dyspepsia (ORCHID) Study Group. BMJ 318:833–837, 1999
Blum AL, Talley NJ, O'Morain C, Van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 339:1875–1881, 1998
Talley NJ, Vakil N, Ballard II D, Fennerty MB: Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 341:1106–1111, 1999
McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones RP, Hilditch T: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 339:1869–1874, 1998
Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU: Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 62:1557–1565, 1994
Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ: Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 90:913–918, 1992
Holtmann G, Talley NJ, Mitchell H, Hazell S: Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer disease, and health. Am J Gastoenterol 93:1222–1227, 1998
Malagelada JR, Stanghellini V: Manometric evaluation of functional upper gut symptoms. Gastroenterology 88:1223–1231, 1985
Lemann M, Dederding JP, Flourie B, Franchisseur C, Rambaud JC, Jian R: Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci 36:1249–1254, 1991
Bradette M, Pare P, Douville P, Morin A: Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci 36:52–58, 1991
Kellow JE, Eckersley CM, Jones MP: Enhanced perception of physiological intestinal motility in the irritable bowel syndrome. Gastroenterology 101:1621–1627, 1991
Holtmann G, Goebell H, Talley NJ: Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 91:485–491, 1996
Mearin F, DeRibot X, Balboa A, Salas A, Varas MJ, Cucala M, Bartolomé R, Armengol JR, Malagelada JR: Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 37:47–51, 1995
Holtmann G, Talley NJ, Goebell H: Association between H. pylori, duodenal mechanosensory thresholds and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci 41:1285–1291, 1996
Gschossmann J, Holtmann G, Bünger L, Gerken G: Long term effects of an acute chemically induced colitis on the visceromotor response to mechanical colorectal distension. Gastroenterology 2000 (in press)
Vaira D, Miglioli M, Mule P, Holton J, Menegatti M, Vergura M, Biasco G, Conte R, Logan RPH, Barbara L: Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 35:309–312, 1994
Anand BS, Malaty H, Genta RM, Graham DY: Peptic ulcer is rare in asymptomatic adults with Helicobacter pylori infection. Gut 37:A10, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holtmann, G., Gschossmann, J., Holtmann, M. et al. H. pylori and Functional Dyspepsia. Dig Dis Sci 46, 1550–1557 (2001). https://doi.org/10.1023/A:1010612509593
Issue Date:
DOI: https://doi.org/10.1023/A:1010612509593